News
4d
Clinical Trials Arena on MSNNeurocrine begins Phase III programme for schizophrenia treatmentThe primary goal of the trial is to measure the decrease in the Positive and Negative Syndrome Scale from baseline.
According to the World Health Organization (WHO), over 22% of the global population smokes, with more than 9 million ...
Compared with placebo, xanomeline/trospium as an add-on to atypical antipsychotics has not reached the threshold for a ...
New Delhi: The pharmaceutical major Cipla has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) for conducting Phase III ...
Researchers from China Pharmaceutical University and Jiangsu Nhwa Pharmaceutical Co. Ltd. have synthesized azetidine-containing compounds acting as muscarinic M4 receptor positive allosteric ...
These findings are consistent with previous studies showing that cholinergic compounds like arecoline can alter hippocampal function by activating muscarinic and nicotinic acetylcholine receptors ...
ACh is produced by the enzyme choline acetyltransferase and its actions are mediated through two types of acetylcholine receptors (AChRs) — the G protein-coupled muscarinic AChRs and the ...
The human body relies on three kinds of opioid receptors to regulate pain, much like traffic control systems on a busy highway. Understanding these pathways is key to developing safer pain treatments.
Integrative Science Center of Germplasm Creation in Western China (CHONGQING) Science City, Citrus Research Institute, Southwest University, Chongqing 400712, China National Citrus Engineering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results